Learn about The Efficacy And Safety Of Iglarlixi Versus Idegasp In Chinese People With Type 2 Diabetes Suboptimally Controlled With Oral Antidiabetic Drugs The Soli D Randomized Controlled Trial History in Quantapedia.
Powered by Quantum Pulse Intelligence